Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Accolade, Inc.
Accolade, Inc. News
Accolade, Inc. Quantitative Score
About Accolade, Inc.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade, Inc. Earnings & Revenue
Accolade, Inc. Financials
Table Compare
Compare ACCD metrics with: | |||
|---|---|---|---|
Earnings & Growth | ACCD | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ACCD | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ACCD | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ACCD | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Accolade, Inc. Income
Accolade, Inc. Balance Sheet
Accolade, Inc. Cash Flow
Accolade, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Accolade, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Accolade, Inc. Executives
| Name | Role |
|---|---|
| Mr. Rajeev Singh | Chairman of the Board & Chief Executive Officer |
| Mr. Robert Cavanaugh | President |
| Mr. Stephen H. Barnes CPA | Chief Financial Officer & Treasurer |
| Mr. Richard Eskew J.D. | Executive Vice President, General Counsel, CCO & Secretary |
| Dr. Shantanu Nundy M.B.A., M.D. | Executive Vice President, Chief Health Officer & Member of the Medical Advisory Board |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Rajeev Singh | Chairman of the Board & Chief Executive Officer | Male | 1968 | 503.5K |
| Mr. Robert Cavanaugh | President | Male | 1969 | 413.5K |
| Mr. Stephen H. Barnes CPA | Chief Financial Officer & Treasurer | Male | 1971 | 403.5K |
| Mr. Richard Eskew J.D. | Executive Vice President, General Counsel, CCO & Secretary | Male | 1975 | 353.5K |
| Dr. Shantanu Nundy M.B.A., M.D. | Executive Vice President, Chief Health Officer & Member of the Medical Advisory Board | -- |
Accolade, Inc. Insider Trades
| Date | 25 Mar |
| Name | Cavanaugh Robert N |
| Role | President |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2500 |
| Date | 25 Mar |
| Name | Eskew Richard |
| Role | EVP General Counsel |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 639 |
| Date | 25 Mar |
| Name | Barnes Stephen H. |
| Role | Chief Financial Officer |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 1703 |
| Date | 17 Mar |
| Name | SINGH RAJEEV |
| Role | Chief Executive Officer |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 933 |
| Date | 18 Mar |
| Name | SINGH RAJEEV |
| Role | Chief Executive Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 289 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 25 Mar | Cavanaugh Robert N | President | Acquired | A-Award | 2500 |
| 25 Mar | Eskew Richard | EVP General Counsel | Acquired | A-Award | 639 |
| 25 Mar | Barnes Stephen H. | Chief Financial Officer | Acquired | A-Award | 1703 |
| 17 Mar | SINGH RAJEEV | Chief Executive Officer | Acquired | M-Exempt | 933 |
| 18 Mar | SINGH RAJEEV | Chief Executive Officer | Disposed | S-Sale | 289 |